In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced…
karnottJanuary 3, 2024
Explore Now
News and Articles
Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal…
karnottJanuary 3, 2024
Somatosensory neurons extend enormous peripheral axons to the skin, where they detect diverse environmental stimuli.…
karnottJanuary 2, 2024
The holiday season is here, and as research begins to slow towards the end of…
karnottDecember 18, 2023
RNA design company Wayfinder Biosciences announced today that it raised a $3.5 million series seed round led…
sciencecityNovember 2, 2022
Jazz Pharmaceuticals and Zymeworks Inc entered into a $50 million licensing agreement over zanidatamab, Zymeworks’ bispecific antibody targeting HER2,…
sciencecityOctober 31, 2022
Dr. Maves is an Associate Professor in the Center for Developmental and Regenerative Medicine at…
sciencecityOctober 31, 2022
People with a genital infection of the herpes simplex virus type 1 (HSV-1), which usually…
sciencecityOctober 28, 2022
News and Articles
Many growth factors and cytokines signal by binding to the extracellular domains of their receptors…
sciencecityJune 18, 2024
Seattle startup Cyrus Biotechnology is spinning out a business that will expand access to the company’s software…
sciencecityJune 18, 2024
Summer is just around the corner, and with it, more opportunities to have fun and…
karnottJune 17, 2024
Upcoming Events in Seattle
Stay up-to-date with all of the life science events taking place in Seattle with the Science in Seattle events calendar!
